Evaluation of the ProstaPlant Prostate Stent Insertion in Ex Vivo Human Prostate
Phase 1
- Conditions
- Benign Prostatic Hyperplasia
- Registration Number
- NCT00468026
- Lead Sponsor
- ProstaPlant Urology System Ltd.
- Brief Summary
The purpose of this ex-vivo study is to evaluate the insertion procedure for the ProstaPlant implant in human prostates and the support that it supplies to the prostate.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- Male
- Target Recruitment
- Not specified
Inclusion Criteria
- Males,
- 18 years old and up,
- Suffer from BPH,
- Candidate for radical prostatectomies
Exclusion Criteria
- According to the physician's decision
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method This is a feasibility study, in which initial evaluation of stent insertion procedure is obtained
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
"Asuta" Medical Center
🇮🇱Tel-Aviv, Israel